DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Thrombate III (Antithrombin III) - Current Clinical Trials


Thrombate III Related Clinical Trials

Recombinant Human Antithrombin (rhAT) in Patients With Hereditary Antithrombin Deficiency Undergoing Surgery or Delivery [Completed]

Study to Assess Recombinant Human Antithrombin in Patients With Hereditary Antithrombin Deficiency Undergoing Surgery or Delivery [Completed]

Use of Antithrombin in Cardiac Surgery With Cardiopulmonary Bypass [Recruiting]

Safety, Pharmacokinetics and Efficacy of an AT-III Concentrate. [Recruiting]

Antithrombin III Supplementation for Cardiopulmonary Bypass in Neonates [Recruiting]

Study of Administration Of Antithrombin in Patients With Low Plasmatic Levels of Antithrombin After Cardiac Surgery [Recruiting]

A Study of KW-3357 in Congenital Antithrombin Deficiency [Recruiting]

Antithrombin Enhancement May Improve Anticoagulation Efficiency in Infants Undergoing Cardiopulmonary Bypass for Cardiac Surgery [Recruiting]

Recombinant Human Antithrombin (ATryn«) in the Treatment of Patients With DIC Associated With Severe Sepsis [Recruiting]

An Open-label Study of KW-3357 [Recruiting]

Prevention of Thrombosis Recurrence in Patients With Low Circulating Levels of Antithrombin. [Recruiting]

Understanding "Heparin Resistance" in Cardiac Surgery [Recruiting]

Factor Xa Inhibitor for Prevention of Venous Thromboembolism in Patients Undergoing Elective Total Knee Replacement [Recruiting]

Direct Factor Xa Inhibitor YM150 for Prevention of Stroke in Subjects With Non-Valvular Atrial Fibrillation [Recruiting]

Phase 2 Study of the Safety, Tolerability and Pilot Efficacy of Oral Factor Xa Inhibitor Betrixaban Compared to Warfarin [Recruiting]

Deep Vein Thrombosis Treatment With the Oral Direct Factor Xa Inhibitor Rivaroxaban in Patients Using a Strong CYP 3A4 Inducer [Recruiting]

Factor Xa Inhibitor, PRT054021, Against Enoxaparin for the Prevention of Venous Thromboembolic Events (EXPERT) [Completed]

Factor Xa Inhibitor YM150 for the Prevention of Blood Clot Formation in Veins After Scheduled Hip Replacement (ONYX-2) [Completed]

Oral Direct Factor Xa-Inhibitor Apixaban in Patients With Acute Symptomatic Deep-Vein Thrombosis-The Botticelli DVT Study [Completed]

A Phase 1 Safety, Pharmacokinetics And Pharmacodynamics Study Of PF-05280602, A Recombinant Factor VIIa Variant (813d), In Adult Subjects With Hemophilia A Or B [Recruiting]

Pharmacodynamics Aspects Of Porcine Heparin Sodium, Produced by Eurofarma, Compared Heparin Sodium, Produced by APP Pharmaceuticasls, in Patients With Chronic Renal Failure [Not yet recruiting]

A Study of DU-176b in Preventing Blood Clots After Hip Replacement Surgery [Completed]

An Oral, Direct Factor Xa Inhibitor, BAY 59-7939, for Prophylaxis Against Venous Thromboembolism After Total Knee Replacement: a Dose-Ranging Study [Completed]

Once-Daily Oral Direct Factor Xa Inhibitor BAY 59-7939 in Patients With Acute Symptomatic Deep-Vein Thrombosis. The Einstein-DVT Dose-Finding Study [Completed]

Antithrombin III in Infants With Cardiopulmonary Bypass (CPB) [Recruiting]

Study of Abnormal Blood Clotting in Children With Stroke [Recruiting]

Anti-thrombin III (ATIII) vs Placebo in Children (<6mo) Undergoing Open Congenital Cardiac Surgery [Recruiting]

BMS-562247 in Subjects Undergoing Elective Total Knee Replacement Surgery [Completed]

The SEPIA-PCI Trial: Otamixaban in Comparison to Heparin in Subjects Undergoing Non-Urgent Percutaneous Coronary Intervention [Completed]

A Phase 3 Clinical Study of KW-3357 in Patients With DIC [Recruiting]

Effects of the Concentrated Extract of Soy on Coagulation Factors After Menopause [Not yet recruiting]

A Study to Investigate Biomarkers After Single Doses of Anticoagulants in Healthy Young Male and Healthy Elderly Participants (MK-0000-216 AM1) [Recruiting]

A Study Evaluating Safety and Tolerability of YM150 Compared to Warfarin in Subjects With Atrial Fibrillation [Recruiting]

Prolonged Hemodialysis Catheter Survival With Copolymer Coating and Rt-PA [Recruiting]

A Multinational Study to Evaluate the Effects of a 28-Day Oral Contraceptive on Hemostatic Parameters in Healthy Women [Recruiting]

Low-Dose Tamoxifen Citrate in Reducing Breast Cancer Risk in Radiation-Induced Cancer Survivors [Recruiting]

Phase IIa Venous Thromboembolism (VTE) Prevention Study In Total Knee Replacement (TKR) [Terminated]

A Clinical Study of KW-3357 in Patients With DIC [Recruiting]

The Change of Coagulation Markers in Children With ╬▓-Thalassemia Disease After Stem Cell Transplantation [Recruiting]

A Study to Evaluate Efficacy and Safety of TAK-442 in Subjects Undergoing Total Knee Replacement [Recruiting]

A Study to Evaluate Ovarian Follicular Activity and Hormone Levels for DR-102 Compared to Two 28-Day Oral Contraceptives [Recruiting]

Heparin Anticoagulation to Improve Outcomes in Septic Shock: The HALO Pilot [Recruiting]

Exploring the Efficacy and Safety of Rivaroxaban to Support Elective Percutaneous Coronary Intervention [Recruiting]

The Effect of a Levonorgestrel-releasing Intrauterine Device (IUD) Versus a Copper Containing IUD on Risk of Blood Clots [Recruiting]

Aspirin for Treatment of Severe Sepsis [Not yet recruiting]

Thromboelastography in in Patients With Sepsis [Recruiting]

Trial of Low Dose Tamoxifen in Women With Breast Intraepithelial Neoplasia [Recruiting]

Hypercoagulability After Breast Cancer Surgery [Completed]

Birth Control Pill vs Birth Control Patch Study [Completed]

Reduction of Heparin Dose in Dialysis With Evodial System [Recruiting]

Investigate Impact of Yasmin vs Microgynon on Hemostasis Parameters in Healthy Women [Completed]

Tinzaparin in Treating Patients With Metastatic Kidney Cancer That Cannot Be Removed By Surgery [Active, not recruiting]

The Effect of the Mini-Pill on Blood Factors in Women at Increased Risk for Forming Blood Clots [Recruiting]

Effects on Hemostasis, Lipids, Carbohydrate Metabolism, Adrenal & Thyroid Function of the Combined Oral Contraceptive NOMAC-E2 Compared to a COC Containing LNG/EE [Completed]

The Use of Fondaparinux in Preventing Thromboembolism in High Risk Trauma Patients [Recruiting]

Twice-daily Oral Direct Thrombin Inhibitor Dabigatran Etexilate in the Long Term Prevention of Recurrent Symptomatic VTE [Recruiting]

Long Term Effects of Erythrocyte Lysis [Recruiting]

-- advertisement -- The American Red Cross
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2015